Quest Diagnostics Q1 2026 Revenue Outlook and Guidance Updates

Q1 2026 outlook for Quest Diagnostics’ revenue growth

1) What Quest actually reported for Q1 2026 (starting point)

Quest said it delivered “a strong focused business” and that during the first quarter it grew revenues over 9% with growth “almost entirely from organic revenue growth.” ¹
Quest also quantified the topline and volume mechanics:

• Consolidated revenues: $2.9 billion, up 9.2% vs. the prior year. ²
• Organic revenues: grew by 9% in the quarter. ²
• Total requisitions (volume): up 10.9% YoY; organic volume up 10.8%. ²
• Fresenius + Corewell contribution: ~7% of organic volume growth; organic volume growth was 3.8% excluding that contribution. ³²

Bottom line on Q1 2026 revenue growth: the “outlook” based on the quarter’s realized performance is that Quest is already demonstrating a ~9%+ revenue growth rate, heavily supported by organic growth rather than purely by mix from large relationships. ¹²

2) Management’s forward-looking posture for Q2–Q4 (what it implies for “outlook” expectations)

Quest did not provide a standalone “Q1-to-Q2” revenue growth forecast number in the excerpt, but it did give a clear message about the balance of the year and drivers that investors would map into expectations:

• Quest guided that for the balance of the year (Q2 to Q4) it is looking for “continued growth” in “organic utilization”. ³
• It also reiterated continued impact from Corewell: Corewell was described as a ~$250 million impact for the year in terms of revenue growth impact. ³

Implication for investor expectations around near-term growth: because the company characterized Q2–Q4 as continuing organic utilization growth, investors would generally extend the Q1 organic momentum into the rest of 2026, while adjusting for the Corewell-driven revenue growth impact. ³²

---

How guidance changes could affect investor expectations

1) Quest raised full-year revenue guidance after strong Q1 execution

Management stated: “Given our first quarter momentum, we are raising our guidance for the full year.” ⁴
In updated 2026 guidance, Quest provided specific revenue targets:

• 2026 revenues: $11.78 billion to $11.9 billion, implying 6.8% to 7.8% growth. ⁵
• The guidance explicitly notes the revenue guide “does not include any contribution from prospective M&A.” ⁵

Why this matters for expectations: the fact that Quest raised guidance after a quarter with ~9% revenue growth strengthens the market narrative that the company’s organic drivers are sustainable enough to support a higher confidence range for the full year—even though full-year growth guided (6.8%–7.8%) is lower than the Q1 print due to mix/cadence and non-linear drivers. ⁴¹⁵

2) The guidance raise also signals expectations for earnings power (which can lift revenue confidence)

Quest raised both revenue and EPS guidance, not just revenue. ⁴⁵
It previously described Q1 profitability support from productivity:

• Adjusted EPS grew ~13% in Q1, supported by productivity benefits from automation and AI. ¹
• Quest quantified the quarter’s financial drivers: increased operating income was primarily due to organic revenue growth and increased productivity, partially offset by wage increases and to a lesser extent, weather. ²

Why investors might re-rate expectations: when management ties raised guidance to organic revenue growth + productivity, it often reduces investor perceived downside risk around cost/efficiency translating into revenue sustainability (because the productivity programs help execution). ²⁴

3) “Q1 momentum” and mix effects: guidance changes can cause expectation shifts on quality of growth

Investors typically distinguish between:

• growth from organic utilization and test-per-requisition, and
• growth affected by relationship mix (e.g., Corewell/Fresenius).

Quest reported that:

• Organic volume growth was 3.8% excluding the Corewell/Fresenius relationships, indicating the quarter’s total growth included a meaningful mix component. ³
• Total revenue per requisition was down 1.3% due to mix, while excluding Corewell/Fresenius it was up ~2.5%. ³²
• The key driver of the +2.5% (ex-mix) revenue per requisition was “test per requisition,” with management emphasizing it should remain solid. ³

Net effect on investor expectations from guidance changes: raised full-year guidance after a quarter where management highlighted test-per-requisition strength (and clarified mix headwinds) can lead investors to focus more on organic utilization + test intensity rather than the less “durable-looking” mix effects. ³⁵⁴

---

Direct answer (concise)

• Q1 2026 revenue growth: Quest reported consolidated revenues up 9.2% YoY (and revenues grew over 9%), with growth almost entirely from organic revenue growth. ²¹
• Outlook implied by management: for the balance of 2026 (Q2–Q4), Quest expects continued organic utilization growth while still facing ongoing revenue impact considerations tied to Corewell (~$250 million impact for the year). ³
• Impact of guidance changes on investor expectations: Quest raised full-year 2026 revenue guidance to $11.78–$11.9B (6.8%–7.8% growth), explicitly excluding prospective M&A, signaling higher confidence in the durability of organic demand and execution after Q1 momentum; this often leads investors to revise expectations upward for revenue credibility—especially when management links the upside to organic growth and productivity/AI while separately explaining mix effects on revenue per requisition. ⁴⁵²³